309 related articles for article (PubMed ID: 35959796)
21. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
[TBL] [Abstract][Full Text] [Related]
22. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
[TBL] [Abstract][Full Text] [Related]
23. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer.
Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J
Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513
[TBL] [Abstract][Full Text] [Related]
24. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
[TBL] [Abstract][Full Text] [Related]
25. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
26. Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study.
Cibula D; Akilli H; Jarkovsky J; van Lonkhuijzen L; Scambia G; Meydanli MM; Ortiz DI; Falconer H; Abu-Rustum NR; Odetto D; Klát J; Dos Reis R; Zapardiel I; Di Martino G; Presl J; Laky R; López A; Weinberger V; Obermair A; Pareja R; Poncová R; Mom C; Bizzarri N; Borčinová M; Aslan K; Salcedo Hernandez RA; Fons G; Benešová K; Dostálek L; Ayhan A
Gynecol Oncol; 2023 Mar; 170():195-202. PubMed ID: 36706646
[TBL] [Abstract][Full Text] [Related]
27. Surgical pathologic factors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival.
Piura B; Rabinovich A; Friger M
Eur J Gynaecol Oncol; 2006; 27(6):573-8. PubMed ID: 17290585
[TBL] [Abstract][Full Text] [Related]
28. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
30. Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
Nasioudis D; Latif NA; Giuntoli Ii RL; Haggerty AF; Cory L; Kim SH; Morgan MA; Ko EM
Int J Gynecol Cancer; 2021 Jun; 31(6):829-834. PubMed ID: 33962994
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
Yanaranop M; Sathapornteera N; Nakrangsee S
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
[TBL] [Abstract][Full Text] [Related]
33. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
[TBL] [Abstract][Full Text] [Related]
34. Tailored radical hysterectomy for locally advanced cervical cancer.
Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
[TBL] [Abstract][Full Text] [Related]
35. Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study.
Liang C; Jiang H; Sun L; Kang S; Cui Z; Wang L; Zhao W; Bin X; Lang J; Liu P; Chen C
Eur J Surg Oncol; 2023 Sep; 49(9):106936. PubMed ID: 37244844
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
37. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
38. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
39. Parametrial involvement in women with low-risk, early-stage cervical cancer.
Vanichtantikul A; Tantbirojn P; Manchana T
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27704641
[TBL] [Abstract][Full Text] [Related]
40. A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix.
van der Velden J; Samlal R; Schilthuis MS; Gonzalez DG; ten Kate FJ; Lammes FB
Gynecol Oncol; 1999 Nov; 75(2):233-7. PubMed ID: 10525378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
